Aranex Nasal Spray (Mometasone Furoate)

Adult use

Allergic rhinitis: spray twice in each nostril once daily (total daily dose 0.2 mg). If symptoms are relieved, the dosage can be reduced to once in each nostril once daily (total daily dose 0.1 mg). If symptoms persist, the dosage can be increased to a maximum of 4 sprays in each nostril once daily (total daily dose 0.4 mg). Nasal polyps: spray twice in each nostril once daily (total daily dose 0.

Child use

Allergic rhinitis: children aged 2 to 11 years should spray once in each nostril once a day (total daily dose 0.1 mg).

This medication is a corticosteroid for nasal use, which helps to reduce inflammation and relieve allergy symptoms. This medication should not be used in patients with an allergy to this medication or its components, those with untreated nasal mucosal infections, patients who have recently had nasal surgery or have wounds in the nose, and children under 2 years of age. Patients with active respiratory tuberculosis or fungal, bacterial, or viral infections, patients with recurrent nosebleeds, those at risk of infections such as chickenpox or measles, patients with specific nasal disorders, pregnant women or those who may become pregnant, and nursing mothers should use this medication with caution. While using this medication, side effects such as headaches, viral infections, pharyngitis, nosebleeds, coughing, and upper respiratory tract infections may occur, and in rare cases, serious allergic reactions such as anaphylaxis may develop, so if any unusual symptoms occur, use should be stopped immediately and medical consultation sought. Long-term use at high doses may result in systemic corticosteroid side effects, so caution is advised, especially if there are symptoms of nasal infection or changes in the nasal mucosa that require regular testing. This medication is important for infection prevention and prompt treatment in patients at risk of exposure to chickenpox or measles, and its effects may not be fully evident within 48 hours of the first use. Careful monitoring of growth is necessary in children due to the possibility of growth delay; safety has not been established for children under 2 years. Elderly patients may have diminished physiological functions, so their condition should be closely observed and the medication used cautiously. If overdosed, no specific treatment is required; however, systemic corticosteroid side effects may occur, so caution is necessary. Before use, the container should be shaken well, and if it has not been used for a certain period, a test spray should be done to confirm uniform spraying, and it should not be sprayed directly into the eyes or on the septum, but only into the nasal cavity. Keep out of reach of children; no specific effects have been reported when driving or operating machinery.

Serious side effects

Hives, severe swelling (edema), difficulty breathing, symptoms of anaphylaxis (difficulty breathing, generalized flushing, angioedema, hives), nasal ulcers, oral and nasal candidiasis, severe allergic reactions, generalized flushing, angioedema accompanied by increased blood pressure and severe swelling, liver dysfunction, elevated ALT, elevated AST, increased blood bilirubin levels, elevated blood alkaline phosphatase levels.

Mild side effects

• Headaches
• viral infections
• pharyngitis
• nosebleeds/blood-tinged mucus
• coughing
• upper respiratory tract infections
• menstrual disorders
• musculoskeletal pain
• sinusitis
• vomiting

This medication may be sensitive to air and moisture, so it should be stored in a sealed container. The appropriate storage temperature is in a cool place between 2 and 25 degrees Celsius, and it is advisable to avoid direct sunlight.

Appearance

An opaque suspension that is white or nearly white contained in a dispenser that sprays a certain amount.

Package unit

18 milliliters/bottle